We reported a case of PMP arising from an ovarian mucinous borderline tumor with a KRAS mutation, which achieved complete remission with a bevacizumab-containing chemotherapy regimen. This evidence concerns the gene KRAS and Borderline Ovarian Mucinous Tumor.